SHOULDER INNOVATIONS, INC.
SINYSE
$21.59
↓ -4.2%Jul 17 close · end-of-day
Price
1Y↑ +43.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$445.9M
Enterprise Value
$352.3M
P/E
0.5
P/S
8.3
P/B
3.4
EV/EBITDA
—
PEG
—
FCF Yield
-9.8%
Dividend Yield
—
Revenue (TTM)
$53.9M
Net Income (TTM)
-$44.1M
Free Cash Flow (TTM)
-$43.8M
Gross Margin
76.8%
Operating Margin
-57.5%
Net Margin
-81.8%
ROE
-33.1%
ROIC
-62.1%
Debt / Equity
0.1
Net Cash
$93.6M
Return 1Y
—
Company profile
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. Our principal executive offices are located in Grand Rapids, MI.
- CEO
- Robert Ball
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 61
- Headquarters
- Michigan
- Website
- shoulderinnovations.com/
Management & directors
- Ahearn Matthew FraserChief Operating Officer
- Ball Robert JosephCEO & Executive Chairman
- Points Jeffrey S.Chief Financial Officer
- Blue David LawrenceSee Remarks
Roles derived from SEC Form 4 filings.
Earnings
SI Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$16.7M↑ +64.9%
Diluted EPS-$0.41↓ -99.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2024 | FY2025 |
|---|---|---|
| Revenue | $31.6M | $47.3M |
| Gross profit | $24.3M | $36.2M |
| Operating income | -$14.7M | -$26.3M |
| Net income | -$15.6M | -$40.4M |
| Diluted EPS | -$242.04 | -$4.65 |
| Operating cash flow | -$14.1M | -$28.6M |
| Free cash flow | -$18.2M | -$36.0M |
| Gross margin | 77.0% | 76.5% |
| Operating margin | -46.3% | -55.6% |
| Net margin | -49.4% | -85.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.3M | $7.5M | — | $10.1M | $11.0M | $11.8M | $14.4M | $16.7M |
| Gross profit | $6.4M | $5.7M | — | $7.8M | $8.4M | $9.0M | $11.1M | $13.0M |
| Operating income | -$4.0M | -$3.9M | — | -$4.3M | -$5.9M | -$7.6M | -$8.5M | -$9.0M |
| Net income | -$4.2M | -$4.1M | -$3.8M | -$4.7M | -$19.2M | -$8.7M | -$7.8M | -$8.4M |
| Diluted EPS | -$72.74 | -$68.31 | — | -$52.13 | -$165.53 | -$0.64 | $213.65 | -$0.41 |
| Operating cash flow | — | -$4.9M | — | -$6.5M | -$4.8M | -$8.6M | -$8.8M | -$12.4M |
| Free cash flow | — | -$5.8M | — | -$7.3M | -$6.3M | -$11.4M | -$11.1M | -$15.1M |
| Gross margin | 76.9% | 76.5% | — | 76.9% | 76.2% | 76.2% | 76.7% | 77.7% |
| Operating margin | -48.2% | -52.1% | — | -42.4% | -53.2% | -65.0% | -59.0% | -53.7% |
| Net margin | -50.5% | -54.4% | — | -46.0% | -174.3% | -74.3% | -53.9% | -50.1% |
Company news
Jun 29, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-26 | BUCKMAN PAUL | Award | 5,046 | $0.00 | $0.00 | filing |
| 2026-06-26 | Sidow Kevin K. | Award | 5,046 | $0.00 | $0.00 | filing |
| 2026-06-26 | Hykes Andrew | Award | 5,046 | $0.00 | $0.00 | filing |
| 2026-06-26 | Tansey Casey M | Award | 5,046 | $0.00 | $0.00 | filing |
| 2026-06-26 | Buchholz Richard | Award | 5,046 | $0.00 | $0.00 | filing |
| 2026-06-15 | Ahearn Matthew Fraser· Chief Operating Officer | Sale | 2,500 | $19.26 | $48,148.00 | filing |
| 2026-06-15 | Ahearn Matthew Fraser· Chief Operating Officer | Sale | 1,644 | $18.20 | $29,921.62 | filing |
| 2026-06-12 | Ahearn Matthew Fraser· Chief Operating Officer | Sale | 15,856 | $18.68 | $296,185.32 | filing |
| 2026-04-30 | Ball Robert Joseph· CEO & Executive Chairman | Option exercise | 10,000 | $2.48 | $24,804.00 | filing |
| 2026-04-20 | Ahearn Matthew Fraser· Chief Operating Officer | Option exercise | 14,243 | $2.86 | $40,763.47 | filing |
| 2026-04-20 | Ahearn Matthew Fraser· Chief Operating Officer | Option exercise | 7,421 | $2.48 | $18,407.05 | filing |
| 2026-03-13 | BUCKMAN PAUL | Tax withholding | 3,714 | $14.82 | $55,041.48 | filing |
| 2026-03-13 | BUCKMAN PAUL | Option exercise | 26,205 | $2.10 | $54,999.05 | filing |
| 2026-03-13 | BUCKMAN PAUL | Tax withholding | 3,292 | $14.62 | $48,129.04 | filing |
| 2026-03-13 | BUCKMAN PAUL | Option exercise | 19,401 | $2.48 | $48,122.24 | filing |
| 2026-03-13 | Ball Robert Joseph· CEO & Executive Chairman | Buy | 2,200 | $15.18 | $33,392.04 | filing |
| 2026-03-13 | Points Jeffrey S.· Chief Financial Officer | Option exercise | 13,264 | $2.48 | $32,900.03 | filing |
| 2026-03-13 | Points Jeffrey S.· Chief Financial Officer | Buy | 2,000 | $15.00 | $30,000.00 | filing |
| 2026-03-13 | Buchholz Richard | Buy | 1,000 | $14.84 | $14,840.00 | filing |
| 2026-02-06 | Ball Robert Joseph· CEO & Executive Chairman | Option exercise | 10,000 | $2.48 | $24,804.00 | filing |
| 2026-02-06 | Ball Robert Joseph· CEO & Executive Chairman | Option exercise | 2,062 | $2.10 | $4,327.73 | filing |
| 2025-12-31 | Ball Robert Joseph· CEO & Executive Chairman | Award | 1,661 | $12.16 | $20,197.76 | filing |
| 2025-12-31 | Points Jeffrey S.· Chief Financial Officer | Award | 1,076 | $12.16 | $13,084.16 | filing |
| 2025-12-31 | Blue David Lawrence· See Remarks | Award | 1,041 | $12.16 | $12,658.56 | filing |
| 2025-12-31 | Ahearn Matthew Fraser· Chief Operating Officer | Award | 477 | $12.16 | $5,800.32 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.